Patents by Inventor Allie Haarstad

Allie Haarstad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Resected Liver Serum for Whole Liver-Engineering
    Publication number: 20250025602
    Abstract: The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
    Type: Application
    Filed: July 29, 2024
    Publication date: January 23, 2025
    Inventors: Jeffrey ROSS, Anne YOUNG, Allie HAARSTAD, Scott NYBERG
  • Use of resected liver serum for whole liver-engineering
    Patent number: 12076461
    Abstract: The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: September 3, 2024
    Assignees: Miromatrix Medical Inc., Mayo Foundation for Medical Education & Research, Mayo Medical Ventures
    Inventors: Jeffrey Ross, Anne Young, Allie Haarstad, Scott Nyberg
  • Use of Resected Liver Serum for Whole Liver-Engineering
    Publication number: 20220323645
    Abstract: The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
    Type: Application
    Filed: February 7, 2022
    Publication date: October 13, 2022
    Inventors: Jeffrey ROSS, Anne YOUNG, Allie HAARSTAD, Scott NYBERG
  • Use of resected liver serum for whole liver-engineering
    Patent number: 11278643
    Abstract: The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: March 22, 2022
    Assignees: Mayo Foundation for Medical Education and Research, Miromatrix Medical Inc.
    Inventors: Jeffrey Ross, Anne Young, Allie Haarstad, Scott Nyberg
  • USE OF RESECTED LIVER SERUM FOR WHOLE LIVER-ENGINEERING
    Publication number: 20180064848
    Abstract: The disclosure provides a method of using blood or fractions thereof, e.g., serum, obtained from a mammal subjected to liver surgery, for example, obtained following a partial hepatectomy, to increase the engraftment, proliferation and/or functionality of cells on a biocompatible scaffold.
    Type: Application
    Filed: September 6, 2017
    Publication date: March 8, 2018
    Inventors: Jeffrey Ross, Anne Young, Allie Haarstad, Scott Nyberg